首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Novel Mechanism of Blood Pressure Regulation By Forkhead Box Class O1–Mediated Transcriptional Control of Hepatic AngiotensinogenNovelty and Significance
【24h】

Novel Mechanism of Blood Pressure Regulation By Forkhead Box Class O1–Mediated Transcriptional Control of Hepatic AngiotensinogenNovelty and Significance

机译:O1型前额箱介导的肝血管紧张素原转录调控的新型血压调控机制及其意义

获取原文
           

摘要

The renin–angiotensin system is a major determinant of blood pressure regulation. It consists of a cascade of enzymatic reactions involving 3 components: angiotensinogen, renin, and angiotensin-converting enzyme, which generate angiotensin II as a biologically active product. Angiotensinogen is largely produced in the liver, acting as a major determinant of the circulating renin–angiotensin system, which exerts acute hemodynamic effects on blood pressure regulation. How the expression of angiotensinogen is regulated is not completely understood. Here, we hypothesize that angiotensinogen is regulated by forkhead transcription factor forkhead box class O1 (Foxo1), an insulin-suppressed transcription factor, and thereby controls blood pressure in mice. We generated liver-specific Foxo1 knockout mice, which exhibited a reduction in plasma angiotensinogen and angiotensin II levels and a significant decrease in blood pressure. Using hepatocyte cultures, we demonstrated that overexpression of Foxo1 increased angiotensinogen expression, whereas hepatocytes lacking Foxo1 demonstrated a reduction of angiotensinogen gene expression and partially impaired insulin inhibition on angiotensinogen gene expression. Furthermore, mouse angiotensinogen prompter analysis demonstrated that the angiotensinogen promoter region contains a functional Foxo1-binding site, which is responsible for both Foxo1 stimulation and insulin suppression on the promoter activity. Together, these data demonstrate that Foxo1 regulates hepatic angiotensinogen gene expression and controls plasma angiotensinogen and angiotensin II levels, modulating blood pressure control in mice.# Novelty and Significance {#article-title-52}
机译:肾素-血管紧张素系统是血压调节的主要决定因素。它由一系列涉及3个成分的酶促反应组成:血管紧张素原,肾素和血管紧张素转化酶,它们产生血管紧张素II作为生物活性产物。血管紧张素原主要在肝脏中产生,是循环中肾素-血管紧张素系统的主要决定因素,该系统对血压调节产生急性血液动力学影响。血管紧张素原的表达如何被调节尚未完全了解。在这里,我们假设血管紧张素原受叉头转录因子叉头盒类O1(Foxo1)(一种胰岛素抑制的转录因子)调节,从而控制了小鼠的血压。我们生成了肝脏特异性Foxo1基因敲除小鼠,该小鼠表现出血浆血管紧张素原和血管紧张素II水平降低,血压显着降低。使用肝细胞培养物,我们证明了Foxo1的过表达增加了血管紧张素原的表达,而缺乏Foxo1的肝细胞显示了血管紧张素原的基因表达减少和胰岛素对血管紧张素原的基因表达的部分抑制。此外,小鼠血管紧张素原促进剂分析表明,血管紧张素原启动子区域包含一个功能性Foxo1结合位点,该位点负责Foxo1刺激和胰岛素对启动子活性的抑制。总之,这些数据表明Foxo1调节肝脏血管紧张素原基因的表达并控制血浆血管紧张素原和血管紧张素II的水平,从而调节小鼠的血压控制。#新颖性和意义{#article-title-52}

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号